Telephone: 781.890.2006
Decision BiomarkersAbout Decision BiomarkersProducts and ServicesTechnologyPress RoomContact
Better decisions through biomarkers. Conduct high-accuracy biomarker analysis quickly and cost-effectively through all stages of drug development. Click here to learn more about the AvantraQ400™Biomarker Workstation
       
Welcome to Decision Biomarkers
Decision Biomarkers, Inc. (DBI) is the leading innovator for automated multiplexed immunoassays.

We have developed a completely automated workstation and a self-contained consumable biochip. These tools enable pharmaceutical and biotech researchers to conduct high-accuracy biomarker analysis quickly and cost-effectively through all stages of drug development.

News and Updates
Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers


As published in Genomeweb's Proteomonitor Magazine, Decision Biomarkers Ships First Workstation - Plans to Make Market Debut in January


Decision Biomarkers awarded U.S. Patent for PATH® Protein Array Surface Chemistry


2008 Conferences:

AACR
Conference Dates: April 12-16, 2008
Exhibit Dates: April 13-16, 2008

Location: San Diego, CA

CHI's PEGS Summit
Conference Dates:
April 28-May 2, 2008
Exhibit Dates: March 26-27, 2008

Location: Boston, MA

CHI's Biomarker World Congress
Conference Dates: May 19-21, 2008
Location: Philadelphia, PA

CHI's Biomarkers Europe
Conference Dates: November 10-11, 2008
Location: Vienna, Austria

 
  Home | About Decision Biomarkers | Products & Services | Technology | Press Room | Contact

©2006 Decision Biomarkers | All rights reserved | Privacy Policy